Su1937 PREDICTORS OF PROGNOSIS AND OUTCOMES AFTER DISCONTINUATION OF FIRST-USE BIOLOGICS IN IBD PATIENTS WITH AT LEAST 24 MONTHS FOLLOW-UP

2020 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []